Skip to main content
OpenTrials

Clinical trial condition

Primary Immunodeficiency Diseases

Explore clinical trials studying Primary Immunodeficiency Diseases. Study availability and eligibility vary by location and protocol.

254 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Primary Immunodeficiency Diseases trial results

Completed

A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II

NCT04130191

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Medical University of Vienna Vienna, Austria
  • Klinikum der Johann-Wolfgang Goethe-Universitat Frankfurt am Main, Hesse, Germany
  • Charité - Universitätsmedizin Berlin Berlin, Germany
  • Universitatsklinikum Dusseldorf Düsseldorf, Germany
View all 19 locations
View Trial Details
Completed

Baby Detect : Genomic Newborn Screening

NCT05687474

Conditions
3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency, +368 more
Locations
  • CRMN, Hôpital La Citadelle Liège, Wallonia, Belgium
View Trial Details
Completed

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II

NCT05047185

Conditions
Angioedema, Angioedemas, Hereditary, C1 Esterase Inhibitor Deficiency, +23 more
Locations
  • Study site Birmingham, Alabama, United States
  • Study site Paradise Valley, Arizona, United States
  • Study site St Louis, Missouri, United States
  • Study Site Vienna, Austria
View all 19 locations
View Trial Details
Completed

A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)

NCT05259917

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • KalVista Investigative Site Birmingham, Alabama, United States
  • KalVista Investigative Site Scottsdale, Arizona, United States
  • KalVista Investigative Site Little Rock, Arkansas, United States
  • KalVista Investigative Site San Diego, California, United States
View all 66 locations
View Trial Details
Completed

A Phase II, Cross-over Clinical Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) in the On-demand Treatment of Angioedema Attacks in Adult Subjects With Hereditary Angioedema Type I or II

NCT04208412

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • KalVista Investigative Site Scottsdale, Arizona, United States
  • KalVista Investigative Site Centennial, Colorado, United States
  • KalVista Investigative Site Chevy Chase, Maryland, United States
  • KalVista Investigative Site Cincinnati, Ohio, United States
View all 25 locations
View Trial Details
Completed

Gene Therapy for Wiskott-Aldrich Syndrome

NCT01515462

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR-TIGET) Milan, Italy
View Trial Details
Completed

OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE)

NCT05139810

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Ionis Investigative Site Scottsdale, Arizona, United States
  • Ionis Investigative Site San Diego, California, United States
  • Ionis Investigative Site Santa Monica, California, United States
  • Ionis Investigative Site Walnut Creek, California, United States
View all 51 locations
View Trial Details

Related conditions